• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高渗起始阻滞对培养的鸡胚细胞胶原蛋白链合成的差异效应。

Differential effect of hypertonic initiation block on the synthesis of collagen chains by cultured chick embryo cells.

作者信息

Pawlowski P J

出版信息

Biochemistry. 1982 Jan 5;21(1):34-8. doi: 10.1021/bi00530a006.

DOI:10.1021/bi00530a006
PMID:6277368
Abstract

The major type of collagen synthesized by fibroblasts or bone cells, type I collagen, consists of two chains normally found in a 2:1 ratio designated alpha 1(I)2 alpha 2(I) or more simply alpha 1(I)2 alpha 2. I have analyzed the relative synthesis of type I chains in these cells under conditions which reduce the initiation of protein synthesis. It was found that in bone cells, which make a large amount of collagen, the alpha 1(I):alpha 2 ratio is unaltered whereas in fibroblasts, which make smaller amounts of collagen, the alpha 2 chain is particularly sensitive to these same conditions. Examination of the collagen secreted into the medium, under these same conditions, also revealed an altered chain ratio from cells making low amounts of collagen.

摘要

成纤维细胞或骨细胞合成的主要胶原蛋白类型,即I型胶原蛋白,由两条链组成,通常以2:1的比例存在,称为α1(I)2α2(I),或更简单地称为α1(I)2α2。我分析了在降低蛋白质合成起始的条件下,这些细胞中I型链的相对合成情况。结果发现,在大量合成胶原蛋白的骨细胞中,α1(I):α2的比例未发生改变,而在合成较少胶原蛋白的成纤维细胞中,α2链对这些相同条件特别敏感。在相同条件下,对分泌到培养基中的胶原蛋白进行检测,也发现来自合成少量胶原蛋白的细胞的链比例发生了改变。

相似文献

1
Differential effect of hypertonic initiation block on the synthesis of collagen chains by cultured chick embryo cells.高渗起始阻滞对培养的鸡胚细胞胶原蛋白链合成的差异效应。
Biochemistry. 1982 Jan 5;21(1):34-8. doi: 10.1021/bi00530a006.
2
Inhibition of collagen secretion from bone and cultured fibroblasts by microtubular disruptive drugs.微管破坏药物对骨和培养的成纤维细胞胶原蛋白分泌的抑制作用。
Proc Natl Acad Sci U S A. 1972 Apr;69(4):892-6. doi: 10.1073/pnas.69.4.892.
3
Control of type I collagen synthesis: evidence for pretranslational coordination of pro alpha 1 (I) and pro alpha 2 (I) chain synthesis in embryonic chick bone.I型胶原蛋白合成的调控:胚胎期鸡骨中α1(I)前体链和α2(I)前体链合成的翻译前协调证据
Connect Tissue Res. 1983;11(2-3):185-91. doi: 10.3109/03008208309004854.
4
Changes in ribosomal RNA, poly(A)+ RNA, and collagen alpha 2(I) mRNA synthesis and processing during hypertonic treatment of cultured chick embryo cells.培养的鸡胚细胞在高渗处理过程中核糖体RNA、多聚腺苷酸加尾RNA以及胶原蛋白α2(I)信使核糖核酸合成与加工的变化。
Exp Cell Res. 1988 Jan;174(1):188-98. doi: 10.1016/0014-4827(88)90154-1.
5
Procollagen assembly and secretion in embryonic chick bone.胚胎期鸡骨中前胶原的组装与分泌
J Biol Chem. 1975 Jul 25;250(14):5719-26.
6
Characterization of the pro- 1 chain of procollagen.前胶原1链的特性分析。
J Biol Chem. 1972 May 10;247(9):2808-13.
7
Impaired conversion of procollagen to collagen by fibroblasts and bone treated with tunicamycin, an inhibitor of protein glycosylation.用衣霉素(一种蛋白质糖基化抑制剂)处理的成纤维细胞和骨骼,原胶原蛋白向胶原蛋白的转化受损。
J Biol Chem. 1977 Feb 10;252(3):955-62.
8
Resistance of Semliki forest virus protein synthesis to high salt treatment.
Acta Virol. 1981 Sep;25(5):257-65.
9
The synthesis of underhydroxylated collagen by 3 T6 mouse fibroblasts in culture.3T6小鼠成纤维细胞在培养中合成低羟基化胶原蛋白。
Biochim Biophys Acta. 1972 Apr 15;263(2):397-405. doi: 10.1016/0005-2795(72)90091-8.
10
Inhibition of collagen synthesis in cultured cells by hypertonic culture medium.
Arch Biochem Biophys. 1977 Jan 30;178(2):373-80. doi: 10.1016/0003-9861(77)90206-5.

引用本文的文献

1
Tissue specificity of type I collagen gene expression is determined at both transcriptional and post-transcriptional levels.I型胶原基因表达的组织特异性在转录和转录后水平上均被确定。
Mol Cell Biol. 1984 Sep;4(9):1843-52. doi: 10.1128/mcb.4.9.1843-1852.1984.
2
Leader length and secondary structure modulate mRNA function under conditions of stress.在应激条件下,前导序列长度和二级结构会调节mRNA的功能。
Mol Cell Biol. 1988 Jul;8(7):2737-44. doi: 10.1128/mcb.8.7.2737-2744.1988.